Bock AM, Gallaway KC, Hund AM Specifying links between executive functioning and theory of mind during middle childhood: Cognitive flexibility predicts social understanding. Journal of Cognition and Development. 2015;16(3):509-21.
Buttelmann F, Karbach J Development and Plasticity of Cognitive Flexibility in Early and Middle Childhood. Front Psychol. 2017 Jun 20;8:1040. doi: 10.3389/fpsyg.2017.01040. eCollection 2017.
Dajani DR, Uddin LQ Demystifying cognitive flexibility: Implications for clinical and developmental neuroscience. Trends Neurosci. 2015 Sep;38(9):571-8. doi: 10.1016/j.tins.2015.07.003.
Friedman NP, Miyake A Unity and diversity of executive functions: Individual differences as a window on cognitive structure. Cortex. 2017 Jan;86:186-204. doi: 10.1016/j.cortex.2016.04.023. Epub 2016 May 10.
Green CS, Bavelier D Learning, attentional control, and action video games. Curr Biol. 2012 Mar 20;22(6):R197-206. doi: 10.1016/j.cub.2012.02.012.
Karbach J, Kray J How useful is executive control training? Age differences in near and far transfer of task-switching training. Dev Sci. 2009 Nov;12(6):978-90. doi: 10.1111/j.1467-7687.2009.00846.x.
Kloo D, Perner J Training transfer between card sorting and false belief understanding: helping children apply conflicting descriptions. Child Dev. 2003 Nov-Dec;74(6):1823-39. doi: 10.1046/j.1467-8624.2003.00640.x.
Papic MM, Mulligan JT, Mitchelmore MC Assessing the development of preschoolers' mathematical patterning. Journal for Research in Mathematics Education. 2011;42(3):237-68.
Uddin LQ Cognitive and behavioural flexibility: neural mechanisms and clinical considerations. Nat Rev Neurosci. 2021 Mar;22(3):167-179. doi: 10.1038/s41583-021-00428-w. Epub 2021 Feb 3.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
